Cow infections could provide clue to preventing infertility in women

Researchers at the Royal Veterinary College, London, have made a significant breakthrough in their understanding of how infection of the uterus damages fertility in cows. Their findings, which show that common uterine infections can damage the ovaries, may provide insights into how to treat infections such as Chlamydia in humans.

Funded by the Wellcome Trust and the Biotechnology and Biological Sciences Research Council, researchers led by Professor Martin Sheldon studied the effect that uterine disease has on the reproductive system in cows. Their findings, published today in the journal Reproduction, suggest that the cow's innate immune system may affect key stages in the reproductive cycle, including suppressing the release of the female sex hormone oestrogen and causing failure to ovulate.

Approximately a million dairy cows get uterine disease each year in the UK, affecting not only milk production but also the cow's ability to reproduce. Cows already have an unusually low chance of conceiving – a 30% chance compared to over 60% in sheep – so if their fertility falls further and they are unable to conceive, they become uneconomical to keep and may be culled.

In cows, uterine disease is usually caused by bacteria entering the uterus after the cow has given birth. The same route of infection can also occur in women; however, humans may also be affected by sexually transmitted infections such as Chlamydia. Although the infections are usually successfully treated with antibiotics, the infertility often persists.

Using the bacterium E. coli, Professor Sheldon and colleagues examined the effect that bacteria have on the granulosa cells that line each egg-containing follicle in the ovary. These granulosa cells nurture the egg until the follicle bursts to release the egg, and they make oestradiol (a form of the sex hormone oestrogen), which encourages the female to copulate. The researchers found that even after treatment of uterine disease, the follicle still contains toxin left over from the breakdown of the pathogen.

The researchers also found that granulosa cells, which protect the egg inside the follicle, play a part in the immune response to infection by recognising that the toxin has entered the follicle and inhibiting production of oestradiol.

"We believe that granulosa cells may play a role in 'quality control' relating to ovulation," says Professor Sheldon. "Infection can potentially damage the genetic make-up of an egg, and these 'errors' would be passed down from generation to generation. By suppressing the release of oestrogen – in effect, reducing sexual behaviour – the granulosa are preventing those defects being passed on."

Professor Sheldon believes that these findings open up a new, previously overlooked, avenue for treating uterine disease in cows.

"The emphasis on treating uterine disease has so far always been on clearing infection in the uterus," he says. "We need to remember that the infection also affects the ovaries and may cause lasting damage. We may need to treat the disease with anti-inflammatory drugs or develop new anti-toxins."

The findings mirror those from research previously carried out in mice, suggesting that granulosa may be a part of the innate immune system in other mammals, possibly including humans.

"It appears that bacteria have a lasting effect on fertility in cattle and possibly humans," says Professor Sheldon. "Our research suggests a mechanism for how this may occur and offers hope for developing new treatments to prevent this from happening."

Source: Wellcome Trust

Related stories:

Menstrual blood -- a valuable source of multipotential stem cells?
Researchers seeking new and more abundant sources of stem cells for use in regenerative medicine have identified a potentially unlimited, noncontroversial, easily collectable, and inexpensive source – menstrual blood.
Uterine stem cells create new neurons that can curb Parkinson's disease
The injection of uterine stem cells trigger growth of new brain cells in mice with Parkinson’s disease, Yale School of Medicine researchers report in an abstract presented at the 2008 Society for Gynecologic Investigation (SGI) Annual Scientific Meeting held March 26-29 in San Diego, California.
Oregon study raises questions on synthetic progestins
The widely used synthetic progestin medroxyprogesterone acetate (MPA) decreased endothelial function in premenopausal women in a study done at the University of Oregon. The finding, researchers said, raises concerns about long-term effects of MPA and possibly other synthetic hormones on vascular health in young women.
Too much sugar turns off gene that controls the effects of sex steroids
Eating too much fructose and glucose can turn off the gene that regulates the levels of active testosterone and estrogen in the body, shows a new study in mice and human cell cultures that’s published this month in the Journal of Clinical Investigation. This discovery reinforces public health advice to eat complex carbohydrates and avoid sugar.
Cervical cancer screening: Too many are left unprotected
The decline in cervical cancer is a success story of cancer research. Although there are reasons to be optimistic about even further decreases in cervical cancer incidence, there still remain some women who are not screened. A meta-analysis by Spence and colleagues published in the August-September 2007 issue of Preventive Medicine shows that undergoing Pap smears irregularly or never was the primary explanation for the development of invasive cervical cancer, followed by false negative tests and poor follow-up of abnormal results.
Smoking, drinking tied to increased cancer
A new report attributes Britain's rising cancer rate to lifestyle choices such as sunbathing, drinking, overeating and smoking.
Common preterm labor drug has more side effects than alternative
The drug most commonly used to arrest preterm labor, magnesium sulfate, is more likely than another common treatment to cause mild to serious side effects in pregnant women, according to a study from researchers at Lucile Packard Children's Hospital and Stanford University School of Medicine. Their findings suggest that, since the effectiveness of the two drugs appears similar, physicians should consider side effects more strongly when choosing which drug to prescribe.
Scientists identify a mouse embryonic stem cell more like our own
Scientists have discovered a new type of mouse embryonic stem cell that is the closest counterpart yet to human embryonic stem (ES) cells, the National Institutes of Health (NIH) announced today. The cells are expected to serve as an improved model for human ES cells in studies of regeneration, disease pathology and basic stem cell biology.

News discussion:

Medicine & Health news